Cargando…
Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441014/ https://www.ncbi.nlm.nih.gov/pubmed/32821983 http://dx.doi.org/10.1007/s00213-020-05644-3 |
| _version_ | 1783573227664048128 |
|---|---|
| author | Martinotti, Giovanni Barlati, Stefano Prestia, Davide Palumbo, Claudia Giordani, Matteo Cuomo, Alessandro Miuli, Andrea Paladini, Carlo Amore, Mario Bondi, Emi Vita, Antonio Fagiolini, Andrea Di Giannantonio, Massimo |
| author_facet | Martinotti, Giovanni Barlati, Stefano Prestia, Davide Palumbo, Claudia Giordani, Matteo Cuomo, Alessandro Miuli, Andrea Paladini, Carlo Amore, Mario Bondi, Emi Vita, Antonio Fagiolini, Andrea Di Giannantonio, Massimo |
| author_sort | Martinotti, Giovanni |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7441014 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74410142020-08-21 Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release Martinotti, Giovanni Barlati, Stefano Prestia, Davide Palumbo, Claudia Giordani, Matteo Cuomo, Alessandro Miuli, Andrea Paladini, Carlo Amore, Mario Bondi, Emi Vita, Antonio Fagiolini, Andrea Di Giannantonio, Massimo Psychopharmacology (Berl) Letter to the Editor Springer Berlin Heidelberg 2020-08-21 2020 /pmc/articles/PMC7441014/ /pubmed/32821983 http://dx.doi.org/10.1007/s00213-020-05644-3 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Martinotti, Giovanni Barlati, Stefano Prestia, Davide Palumbo, Claudia Giordani, Matteo Cuomo, Alessandro Miuli, Andrea Paladini, Carlo Amore, Mario Bondi, Emi Vita, Antonio Fagiolini, Andrea Di Giannantonio, Massimo Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release |
| title | Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release |
| title_full | Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release |
| title_fullStr | Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release |
| title_full_unstemmed | Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release |
| title_short | Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release |
| title_sort | psychomotor agitation and hyperactive delirium in covid-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441014/ https://www.ncbi.nlm.nih.gov/pubmed/32821983 http://dx.doi.org/10.1007/s00213-020-05644-3 |
| work_keys_str_mv | AT martinottigiovanni psychomotoragitationandhyperactivedeliriumincovid19patientstreatedwitharipiprazole975mg13mlimmediaterelease AT barlatistefano psychomotoragitationandhyperactivedeliriumincovid19patientstreatedwitharipiprazole975mg13mlimmediaterelease AT prestiadavide psychomotoragitationandhyperactivedeliriumincovid19patientstreatedwitharipiprazole975mg13mlimmediaterelease AT palumboclaudia psychomotoragitationandhyperactivedeliriumincovid19patientstreatedwitharipiprazole975mg13mlimmediaterelease AT giordanimatteo psychomotoragitationandhyperactivedeliriumincovid19patientstreatedwitharipiprazole975mg13mlimmediaterelease AT cuomoalessandro psychomotoragitationandhyperactivedeliriumincovid19patientstreatedwitharipiprazole975mg13mlimmediaterelease AT miuliandrea psychomotoragitationandhyperactivedeliriumincovid19patientstreatedwitharipiprazole975mg13mlimmediaterelease AT paladinicarlo psychomotoragitationandhyperactivedeliriumincovid19patientstreatedwitharipiprazole975mg13mlimmediaterelease AT amoremario psychomotoragitationandhyperactivedeliriumincovid19patientstreatedwitharipiprazole975mg13mlimmediaterelease AT bondiemi psychomotoragitationandhyperactivedeliriumincovid19patientstreatedwitharipiprazole975mg13mlimmediaterelease AT vitaantonio psychomotoragitationandhyperactivedeliriumincovid19patientstreatedwitharipiprazole975mg13mlimmediaterelease AT fagioliniandrea psychomotoragitationandhyperactivedeliriumincovid19patientstreatedwitharipiprazole975mg13mlimmediaterelease AT digiannantoniomassimo psychomotoragitationandhyperactivedeliriumincovid19patientstreatedwitharipiprazole975mg13mlimmediaterelease |